COc1ccc(-c2c(N)n(-c3cccc(C(=O)O)c3)c(=O)c3cc([N+](=O)[O-])ccc23)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?